Why you should consider using construction digital twin tech, according to this Houston expert

GUEST COLUMN

The benefits of construction digital twins, such as improved planning and design, streamlined collaboration, and effective risk management, are transforming how projects are executed. Photo via Getty Images

The construction industry is no stranger to embracing technological advancements, and one of the latest breakthroughs is the advent of construction digital twin technology.

Blending the virtual and physical worlds, construction digital twins offer immense potential for enhancing efficiency, reducing costs, and improving decision-making in construction projects.

It is a fascinating and ever-changing world of technology in construction digital twin technology and the following information explores its key components, benefits, and real-world applications in the construction sector.

What is a construction digital twin?

A construction digital twin is a virtual replica of a physical asset, process, or system that integrates real-time data from various sources to provide a holistic and dynamic representation. It encompasses a portion of the entire lifecycle of the project, potentially starting from planning and design into construction, commissioning, and data collection for ongoing maintenance.

The key components of a construction digital twin include the physical asset, sensors, data acquisition systems, connectivity infrastructure, cloud platforms, and advanced analytics. Various tools or platforms can be used at different stages of a project.

Skanska, a construction and development company, has created an internal hybrid approach combining a digital twin model with a custom analytics dashboard. The process allows for tracking production control during construction. What is used is a less-is-more approach to manual data entry into models and link to automated external data sources, which are combined and analyzed together in a separate dashboard. These color-coded models are combined with external data for schedule, cost, and man hour data for predictive analysis and production rates.

Improved planning and design

Digital twins allow design and construction professionals to simulate and optimize designs with a virtual model of the building before physically implementing them. This capability enables early detection and resolution of design flaws, reducing rework and costly delays. Adjacent building and city data can inform early design decisions. By leveraging the existing data from a digital twin, renovation projects can streamline processes, reduce risks, improve efficiency, and make informed design decisions, ultimately resulting in more successful and cost-effective renovations.

Enhanced construction processes

A construction digital twin allows stakeholders to visualize and simulate the project, analyze potential issues, optimize workflows, and make informed decisions. Key data sources include: installation, schedule, man hours, and cost. Additional real-time data from sensors embedded in physical assets can be fed into construction digital twins, enabling real-time monitoring and analysis. Project teams can enhance collaboration, improve efficiency, maintain schedule, reduce costs, and minimize risks throughout the construction process.

Effective risk management

Digital twins enable construction companies to simulate and analyze potential risks, such as structural weaknesses and environmental or safety hazards. Builders and their clients are at an advantage since they can address these risks in the virtual environment and significantly reduce the occurrence of accidents and associated liabilities.

Streamlined collaboration

Construction digital twins act as a shared platform for all stakeholders involved in a construction project, including architects, engineers, contractors, and facility managers. This flow of information fosters seamless collaboration, improves communication, and results in better decision-making through a data-driven environment. Solutions vary per stage and parties involved.

Real-world applications

Construction digital twin technology is already finding practical application in the construction industry, including locally at 1550 on The Green, Skanska’s state-of-the art, sustainable office building bringing the outdoors in.

Smart building construction

By creating a digital twin of a smart building, companies can optimize energy efficiency, HVAC systems, and space. The real-time monitoring of energy consumption and occupancy patterns combined with as-built BIM and systems data allows for predictive maintenance. Automations and AI assisted controls are also on the horizon.

Bringing it all together

Construction digital twin technology is poised to revolutionize the construction industry. By merging the virtual and physical realms, it enables construction professionals to make more informed decisions, enhance efficiency, and minimize risks.

The benefits of construction digital twins, such as improved planning and design, streamlined collaboration, and effective risk management, are transforming how projects are executed. As this technology continues to evolve, there are bound to be greater advancements in construction practices, ultimately leading to safer, smarter, and more sustainable built environments. Key data points and use cases vary per phase and stakeholder, and digital twins are a great asset throughout the project lifecycle.

------

Edwin Bailey is senior preconstruction technologist at Skanska, a leading multi-national project development and construction group, in Houston.

From Your Site Articles
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings